You are here

casdatifan

Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say

Fierce Biotech

Thu, 10/24/24 - 08:27 pm

Arcus Biosciences

Arcus and AstraZeneca enter trial collaboration for renal cancer treatment

Clinical Trials Arena

Thu, 10/3/24 - 10:37 am

Arcus Biosciences

renal cell carcinoma